{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,22]],"date-time":"2026-03-22T17:13:41Z","timestamp":1774199621861,"version":"3.50.1"},"reference-count":8,"publisher":"American Society of Hematology","issue":"9","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2002,5,1]]},"DOI":"10.1182\/blood-2001-12-0325","type":"journal-article","created":{"date-parts":[[2002,10,11]],"date-time":"2002-10-11T18:33:52Z","timestamp":1034361232000},"page":"3481-3482","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":39,"title":["Severe neurotoxicity following arsenic therapy for acute promyelocytic leukemia: potentiation by thiamine deficiency"],"prefix":"10.1182","volume":"99","author":[{"given":"Sze-Fai","family":"Yip","sequence":"first","affiliation":[{"name":"Correspondence: Sze-fai Yip, Hematology Division, Dept of Medicine, Tuen Mun Hospital, Hong Kong, China; e-mail:"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiu-Ming","family":"Yeung","sequence":"additional","affiliation":[{"name":"Correspondence: Sze-fai Yip, Hematology Division, Dept of Medicine, Tuen Mun Hospital, Hong Kong, China; e-mail:"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edmond-Yik-Kong","family":"Tsui","sequence":"additional","affiliation":[{"name":"Correspondence: Sze-fai Yip, Hematology Division, Dept of Medicine, Tuen Mun Hospital, Hong Kong, China; e-mail:"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"key":"2020021300142320100_B1","doi-asserted-by":"crossref","first-page":"3852","DOI":"10.1200\/JCO.2001.19.18.3852","article-title":"United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia.","volume":"19","author":"Soignet","year":"2001","journal-title":"J Clin Oncol."},{"key":"2020021300142320100_B2","first-page":"228b","article-title":"Sensorimotor polyneuropathy following arsenic trioxide therapy for relapsed acute promyelocytic leukemia [abstract].","volume":"94(suppl 1)","author":"Densmore","year":"1999","journal-title":"Blood."},{"key":"2020021300142320100_B3","first-page":"1633","article-title":"Cardiac toxicity of arsenic trioxide [letter].","volume":"98","author":"Singer","year":"2001","journal-title":"Blood."},{"key":"2020021300142320100_B4","first-page":"1","article-title":"Biochemistry of some toxic agents; I, present state of knowledge of biochemical lesions induced by trivalent arsenical poisoning.","volume":"97","author":"Peters","year":"1955","journal-title":"Bull John Hopkins Hosp."},{"key":"2020021300142320100_B5","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0921-8777(98)00035-4","article-title":"Arsenic toxicity is enzyme specific and its effects on ligation are not caused by the inhibition of DNA repair enzymes.","volume":"408","author":"Hu","year":"1998","journal-title":"Mutat Res."},{"key":"2020021300142320100_B6","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1182\/blood.V89.9.3354","article-title":"Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL); II, clinical efficacy and pharmacokinetics in relapsed patients.","volume":"89","author":"Shen","year":"1997","journal-title":"Blood."},{"key":"2020021300142320100_B7","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1289\/ehp.7719205","article-title":"Effects of arsenic on pyruvate dehydrogenase activation.","volume":"19","author":"Schiller","year":"1977","journal-title":"Environ Health Perspect."},{"key":"2020021300142320100_B8","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1001\/archderm.1947.01520110080010","article-title":"Relationship between thiamine and arsenic toxicity.","volume":"56","author":"Sexton","year":"1969","journal-title":"Archives of Dermatology and Syphilology."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/99\/9\/3481\/1682985\/h80902003476d.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/99\/9\/3481\/1682985\/h80902003476d.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T05:14:32Z","timestamp":1581570872000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/99\/9\/3481\/53633\/Severe-neurotoxicity-following-arsenic-therapy-for"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,5,1]]},"references-count":8,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2002,5,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2001-12-0325","relation":{},"ISSN":["1528-0020","0006-4971"],"issn-type":[{"value":"1528-0020","type":"electronic"},{"value":"0006-4971","type":"print"}],"subject":[],"published":{"date-parts":[[2002,5,1]]}}}